BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21397148)

  • 1. [Pemphigus: a review].
    Joly P; Sin C
    Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bullous pemphigoid: a review].
    Bernard P; Charneux J
    Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mucous membrane pemphigoid: a review].
    Bédane C; Doffoel Hantz V
    Ann Dermatol Venereol; 2011 Mar; 138(3):201-8. PubMed ID: 21397149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
    Frew JW; Martin LK; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):599-606. PubMed ID: 21925004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions for pemphigus vulgaris and pemphigus foliaceus.
    Martin LK; Werth V; Villanueva E; Segall J; Murrell DF
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006263. PubMed ID: 19160272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus: current therapy.
    Rosenkrantz WS
    Vet Dermatol; 2004 Apr; 15(2):90-8. PubMed ID: 15030557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus vulgaris: approach to treatment.
    Sinha AA; Hoffman MB; Janicke EC
    Eur J Dermatol; 2015 Apr; 25(2):103-13. PubMed ID: 25547117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus.
    Martin LK; Werth VP; Villaneuva EV; Murrell DF
    J Am Acad Dermatol; 2011 May; 64(5):903-8. PubMed ID: 21353333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies for pemphigus vulgaris in Japan.
    Hashimoto T
    Expert Opin Pharmacother; 2008 Jun; 9(9):1519-30. PubMed ID: 18518782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of pemphigus.
    Tsuruta D; Ishii N; Hashimoto T
    Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?
    Tavakolpour S
    Int Immunopharmacol; 2017 Dec; 53():133-142. PubMed ID: 29107213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for bullous pemphigoid.
    Kirtschig G; Middleton P; Bennett C; Murrell DF; Wojnarowska F; Khumalo NP
    Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD002292. PubMed ID: 20927731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
    Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
    Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.
    Porro AM; Hans Filho G; Santi CG
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):20-32. PubMed ID: 31166407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
    Kim MR; Kim HC; Kim SC
    Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pemphigus vulgaris: current and emerging options.
    Yeh SW; Sami N; Ahmed RA
    Am J Clin Dermatol; 2005; 6(5):327-42. PubMed ID: 16252932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pemphigus vulgaris and pemphigus foliaceus: a systematic review and meta-analysis.
    Atzmony L; Hodak E; Gdalevich M; Rosenbaum O; Mimouni D
    Am J Clin Dermatol; 2014 Dec; 15(6):503-15. PubMed ID: 25403548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pemphigus vulgaris. An overview in Mexico.
    Tirado-Sánchez A; León-Dorantes G
    Allergol Immunopathol (Madr); 2006; 34(1):10-6. PubMed ID: 16540065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
    Almugairen N; Hospital V; Bedane C; Duvert-Lehembre S; Picard D; Tronquoy AF; Houivet E; D'incan M; Joly P
    J Am Acad Dermatol; 2013 Oct; 69(4):583-8. PubMed ID: 23850258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.